Desmoid Tumors: A Review of the Literature and Pharmacologic Management

Eellan Sivanesan, Melvin C. Gitlin

Research output: Contribution to journalArticle

Abstract

ABSTRACT: Desmoid tumors represent a nonmalignant proliferation of fibroblast-related cells. These rare tumors are difficult to treat and often persist as indolent, lifelong conditions. There are a number of treatments available for both anatomic and symptom regression. Some of these treatments, unfortunately, may not provide long-lasting results and may result in further complications. Pain is a distressing symptom that may be due to the tumor itself or the result of utilized treatments. Pharmacologic therapies represent a noninvasive alternative to surgical resection. Pain symptoms require therapeutic regimens that must be modified as the tumor evolves in expression. The individualized pain treatment program utilized may often reflect principles used in both nonmalignant and malignant pain management models. This review seeks to increase awareness of desmoid tumors through a review of the literature and discussion of its pharmacotherapeutic management.

Original languageEnglish (US)
Pages (from-to)99-105
Number of pages7
JournalJournal of Pain and Palliative Care Pharmacotherapy
Volume30
Issue number2
DOIs
StatePublished - Apr 2 2016
Externally publishedYes

Fingerprint

Aggressive Fibromatosis
Neoplasms
Pain
Therapeutics
Pain Management
Fibroblasts

Keywords

  • analgesics
  • cancer pain
  • desmoid tumor
  • fibromatosis
  • nonmalignant cancer
  • pain

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Pharmacology (medical)

Cite this

Desmoid Tumors : A Review of the Literature and Pharmacologic Management. / Sivanesan, Eellan; Gitlin, Melvin C.

In: Journal of Pain and Palliative Care Pharmacotherapy, Vol. 30, No. 2, 02.04.2016, p. 99-105.

Research output: Contribution to journalArticle

@article{ce96c2a4464c42e4a0b0e4786de3277e,
title = "Desmoid Tumors: A Review of the Literature and Pharmacologic Management",
abstract = "ABSTRACT: Desmoid tumors represent a nonmalignant proliferation of fibroblast-related cells. These rare tumors are difficult to treat and often persist as indolent, lifelong conditions. There are a number of treatments available for both anatomic and symptom regression. Some of these treatments, unfortunately, may not provide long-lasting results and may result in further complications. Pain is a distressing symptom that may be due to the tumor itself or the result of utilized treatments. Pharmacologic therapies represent a noninvasive alternative to surgical resection. Pain symptoms require therapeutic regimens that must be modified as the tumor evolves in expression. The individualized pain treatment program utilized may often reflect principles used in both nonmalignant and malignant pain management models. This review seeks to increase awareness of desmoid tumors through a review of the literature and discussion of its pharmacotherapeutic management.",
keywords = "analgesics, cancer pain, desmoid tumor, fibromatosis, nonmalignant cancer, pain",
author = "Eellan Sivanesan and Gitlin, {Melvin C.}",
year = "2016",
month = "4",
day = "2",
doi = "10.3109/15360288.2016.1167807",
language = "English (US)",
volume = "30",
pages = "99--105",
journal = "Journal of Pain and Palliative Care Pharmacotherapy",
issn = "1536-0288",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Desmoid Tumors

T2 - A Review of the Literature and Pharmacologic Management

AU - Sivanesan, Eellan

AU - Gitlin, Melvin C.

PY - 2016/4/2

Y1 - 2016/4/2

N2 - ABSTRACT: Desmoid tumors represent a nonmalignant proliferation of fibroblast-related cells. These rare tumors are difficult to treat and often persist as indolent, lifelong conditions. There are a number of treatments available for both anatomic and symptom regression. Some of these treatments, unfortunately, may not provide long-lasting results and may result in further complications. Pain is a distressing symptom that may be due to the tumor itself or the result of utilized treatments. Pharmacologic therapies represent a noninvasive alternative to surgical resection. Pain symptoms require therapeutic regimens that must be modified as the tumor evolves in expression. The individualized pain treatment program utilized may often reflect principles used in both nonmalignant and malignant pain management models. This review seeks to increase awareness of desmoid tumors through a review of the literature and discussion of its pharmacotherapeutic management.

AB - ABSTRACT: Desmoid tumors represent a nonmalignant proliferation of fibroblast-related cells. These rare tumors are difficult to treat and often persist as indolent, lifelong conditions. There are a number of treatments available for both anatomic and symptom regression. Some of these treatments, unfortunately, may not provide long-lasting results and may result in further complications. Pain is a distressing symptom that may be due to the tumor itself or the result of utilized treatments. Pharmacologic therapies represent a noninvasive alternative to surgical resection. Pain symptoms require therapeutic regimens that must be modified as the tumor evolves in expression. The individualized pain treatment program utilized may often reflect principles used in both nonmalignant and malignant pain management models. This review seeks to increase awareness of desmoid tumors through a review of the literature and discussion of its pharmacotherapeutic management.

KW - analgesics

KW - cancer pain

KW - desmoid tumor

KW - fibromatosis

KW - nonmalignant cancer

KW - pain

UR - http://www.scopus.com/inward/record.url?scp=84966714111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966714111&partnerID=8YFLogxK

U2 - 10.3109/15360288.2016.1167807

DO - 10.3109/15360288.2016.1167807

M3 - Article

C2 - 27159399

AN - SCOPUS:84966714111

VL - 30

SP - 99

EP - 105

JO - Journal of Pain and Palliative Care Pharmacotherapy

JF - Journal of Pain and Palliative Care Pharmacotherapy

SN - 1536-0288

IS - 2

ER -